Regenerative Medical Technology Group Inc.
Regenerative Medical Technology Group Inc.
Your view on RMTG
Overview
What the company does, where it operates, and who runs it.
About Regenerative Medical Technology Group Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Eugene Christensen
- Headquarters
- 433 Plaza Real, Boca Raton, FL, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Eugene Christensen
- Headquarters
- 433 Plaza Real, Boca Raton, FL, US
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies.
The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions.
The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Regenerative Medical Technology Group Inc., and the rating behind it. RMTG last traded at $0.04; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Regenerative Medical Technology Group Inc.. Starting points for Regenerative Medical Technology Group Inc.: EPS -$0.72, beta 0.77 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Regenerative Medical Technology Group Inc.. Regenerative Medical Technology Group Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Regenerative Medical Technology Group Inc.. Trailing twelve-month EPS for Regenerative Medical Technology Group Inc. stands at -$0.72. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Regenerative Medical Technology Group Inc.. Regenerative Medical Technology Group Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Regenerative Medical Technology Group Inc. valued side by side against its closest peers. Regenerative Medical Technology Group Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Regenerative Medical Technology Group Inc., and how their positions are changing. At a $488,770 market value, institutional positions materially move Regenerative Medical Technology Group Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Regenerative Medical Technology Group Inc. executives and directors. Shares of Regenerative Medical Technology Group Inc. have traded between $0.02 and $0.08 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Regenerative Medical Technology Group Inc.. Regenerative Medical Technology Group Inc. is a $488,770 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Regenerative Medical Technology Group Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Regenerative Medical Technology Group Inc.. Coverage tracks Regenerative Medical Technology Group Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.